103 results on '"Krueger, James G."'
Search Results
2. Activated Platelets Induce Endothelial Cell Inflammatory Response in Psoriasis Via COX-1
3. Activated Platelets Induce Endothelial Cell Inflammatory Response in Psoriasis via COX-1
4. Inflammasome Signaling and Impaired Vascular Health in Psoriasis
5. Interleukin‐17 alters the biology of many cell types involved in the genesis of psoriasis, systemic inflammation and associated comorbidities
6. Autoantigens ADAMTSL5 and LL37 are significantly upregulated in active Psoriasis and localized with keratinocytes, dendritic cells and other leukocytes
7. Clinically resolved psoriatic lesions contain psoriasis-specific IL-17–producing αβ T cell clones
8. Psoriasis pathogenesis and the development of novel targeted immune therapies
9. Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism
10. Patch testing of food allergens promotes Th17 and Th2 responses with increased IL‐33: a pilot study
11. Major differences between human atopic dermatitis and murine models, as determined by using global transcriptomic profiling
12. Efficacy and safety of ustekinumab treatment in adults with moderate‐to‐severe atopic dermatitis
13. An IL-17–dominant immune profile is shared across the major orphan forms of ichthyosis
14. Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study
15. Biomarkers of alopecia areata disease activity and response to corticosteroid treatment
16. Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism
17. New Insights in the Immunologic Basis of Psoriasis
18. Leprosy is teaching us the immunopathogenesis of inflammatory skin disease
19. Unique microRNAs appear at different times during the course of a delayed-type hypersensitivity reaction in human skin
20. Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing
21. The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization
22. CCL20 and IL22 Messenger RNA Expression After Adalimumab vs Methotrexate Treatment of Psoriasis: A Randomized Clinical Trial
23. Skin-homing and systemic T-cell subsets show higher activation in atopic dermatitis versus psoriasis
24. RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications
25. Comparative Genomic Profiling of Synovium Versus Skin Lesions in Psoriatic Arthritis
26. Patients with atopic dermatitis have attenuated and distinct contact hypersensitivity responses to common allergens in skin
27. Laser capture microdissection followed by next-generation sequencing identifies disease-related microRNAs in psoriatic skin that reflect systemic microRNA changes in psoriasis
28. Humanized anti–IFN-γ (HuZAF) in the treatment of psoriasis
29. The translational revolution and use of biologics in patients with inflammatory skin diseases
30. Dendritic cells are contained within melanocytic nevus nests in vivo and can alter gene expression of epidermal melanocytes in vitro
31. Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissection
32. Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis
33. IDENTIFICATION OF ANAPLASTIC LYMPHOMA KINASE AS A POTENTIAL THERAPEUTIC TARGET IN BASAL CELL CARCINOMA: SYP12-3
34. Residual genomic profile after cyclosporine treatment may offer insights into atopic dermatitis reoccurrence
35. CD200 Upregulation in Vascular Endothelium Surrounding Cutaneous Squamous Cell Carcinoma
36. Petrolatum: Barrier repair and antimicrobial responses underlying this “inert” moisturizer
37. Diverse activation and differentiation of multiple B-cell subsets in patients with atopic dermatitis but not in patients with psoriasis
38. Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen (CLA)+ TH2/TH1 cell imbalance, whereas adults acquire CLA+ TH22/TC22 cell subsets
39. Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response
40. Guselkumab (an IL-23–specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis☆
41. Anti–IL-23A mAb BI 655066 for treatment of moderate-to-severe psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose, randomized, double-blind, placebo-controlled trial
42. Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population
43. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis
44. Interleukins -23 and -17 in patients with palmoplantar pustular psoriasis and palmoplantar pustulosis: P7001
45. Residual genomic signature of atopic dermatitis despite clinical resolution with narrow-band UVB
46. Atopic dermatitis results in intrinsic barrier and immune abnormalities: Implications for contact dermatitis
47. CD200 Upregulation in Vascular Endothelium Surrounding Cutaneous Squamous Cell Carcinoma
48. Progressive activation of TH2/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis
49. Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
50. Association Between Biologic Therapies for Chronic Plaque Psoriasis and Cardiovascular Events: A Meta-analysis of Randomized Controlled Trials
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.